Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-11-047880
Filing Date
2011-08-16
Accepted
2011-08-16 14:43:37
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v231157_10q.htm 10-Q 896348
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SARBANES-OXLEY SECTION 302 v231157_ex31-1.htm EX-31.1 14748
3 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 v231157_ex32-1.htm EX-32.1 5999
  Complete submission text file 0001144204-11-047880.txt   2646525

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT ck0001420030-20110630.xml EX-101.INS 276886
5 XBRL TAXONOMY EXTENSION SCHEMA ck0001420030-20110630.xsd EX-101.SCH 11425
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ck0001420030-20110630_cal.xml EX-101.CAL 39276
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ck0001420030-20110630_def.xml EX-101.DEF 90628
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ck0001420030-20110630_lab.xml EX-101.LAB 100751
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ck0001420030-20110630_pre.xml EX-101.PRE 98344
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Filer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
Type: 10-Q | Act: 34 | File No.: 000-53071 | Film No.: 111039707
SIC: 6770 Blank Checks